Adient plc
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-06-30.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-30.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-30.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: ADNT · Exchange: NYSE · Ordinary Shares, par value $0.001
SEC issuer CIK: 0001670541
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | FY 2024 · 2022-09-30 |
|---|---|---|---|---|---|
| Revenue | $15.13B Filed 2026-08-05 | $14.54B Filed 2025-11-18 | $14.69B Filed 2025-11-18 | $15.4B Filed 2025-11-18 | $14.12B Filed 2024-11-18 |
| Cost of revenue | $14.17B Filed 2026-08-05 | $13.57B Filed 2025-11-18 | $13.76B Filed 2025-11-18 | $14.36B Filed 2025-11-18 | $13.31B Filed 2024-11-18 |
| Gross profit | $956M Filed 2026-08-05 | $961M Filed 2025-11-18 | $928M Filed 2025-11-18 | $1.03B Filed 2025-11-18 | $807M Filed 2024-11-18 |
| Interest expense | $193M Filed 2026-08-05 | $183M Filed 2025-11-18 | $187M Filed 2025-11-18 | $132M Filed 2025-11-18 | $192M Filed 2024-11-18 |
| Pretax income | $246M Filed 2026-08-05 | -$88M Filed 2025-11-18 | $133M Filed 2025-11-18 | $295M Filed 2025-11-18 | $54M Filed 2024-11-18 |
| Income tax expense | $123M Filed 2026-08-05 | $103M Filed 2025-11-18 | $32M Filed 2025-11-18 | $0 Filed 2025-11-18 | $94M Filed 2024-11-18 |
| Net income | $48M Filed 2026-08-05 | -$281M Filed 2025-11-18 | $18M Filed 2025-11-18 | $205M Filed 2025-11-18 | -$120M Filed 2024-11-18 |
| Diluted EPS | Unavailable | -$3.39 Filed 2025-11-18 | $0.20 Filed 2025-11-18 | $2.15 Filed 2025-11-18 | -$1.27 Filed 2024-11-18 |
| Diluted shares | Unavailable | 83M Filed 2025-11-18 | 90.1M Filed 2025-11-18 | 95.4M Filed 2025-11-18 | 94.8M Filed 2024-11-18 |
Balance sheet
| Metric | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | FY 2024 · 2022-09-30 |
|---|---|---|---|---|
| Current assets | $4.13B Filed 2025-11-18 | $4.09B Filed 2025-11-18 | $4.32B Filed 2024-11-18 | $4.16B Filed 2023-11-17 |
| Current liabilities | $3.69B Filed 2025-11-18 | $3.68B Filed 2025-11-18 | $3.74B Filed 2024-11-18 | $3.5B Filed 2023-11-17 |
| Short-term borrowings | $2M Filed 2025-11-18 | $1M Filed 2025-11-18 | $2M Filed 2024-11-18 | $3M Filed 2023-11-17 |
| Total assets | $8.95B Filed 2025-11-18 | $9.35B Filed 2025-11-18 | $9.42B Filed 2025-11-18 | $9.16B Filed 2024-11-18 |
| Stockholders’ equity | $1.77B Filed 2025-11-18 | $2.13B Filed 2025-11-18 | $2.23B Filed 2024-11-18 | $2.07B Filed 2023-11-17 |
Cash flow
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-09-30 | FY 2025 · 2024-09-30 | FY 2025 · 2023-09-30 | FY 2024 · 2022-09-30 |
|---|---|---|---|---|---|
| Operating cash flow | $579M Filed 2026-08-05 | $449M Filed 2025-11-18 | $543M Filed 2025-11-18 | $667M Filed 2025-11-18 | $274M Filed 2024-11-18 |
| Capital expenditures | $284M Filed 2026-08-05 | $245M Filed 2025-11-18 | $266M Filed 2025-11-18 | $252M Filed 2025-11-18 | $227M Filed 2024-11-18 |
| Long-term debt repaid | Unknown | $803M Filed 2025-11-18 | $137M Filed 2025-11-18 | $1.1B Filed 2025-11-18 | $987M Filed 2024-11-18 |
| Stock repurchases | $105M Filed 2026-08-05 | $125M Filed 2025-11-18 | $275M Filed 2025-11-18 | $65M Filed 2025-11-18 | $0 Filed 2024-11-18 |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
Reference valuation uses the latest retained completed-session IEX close and the latest supported SEC-reported share count for a simple single ordinary-share structure.
Open this stock in the Valuation Lab →
Shares outstanding: 77.1M · reported as of 2026-06-30 · filed 2026-08-05
The price is a source-scoped IEX reference close, not a consolidated U.S. market close. P/E and enterprise-value multiples are omitted unless compatible common-equity earnings and complete financing scope are established rather than inferred from adjacent statement fields.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.